Alaethes Wealth LLC Lowers Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Alaethes Wealth LLC decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 4.9% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 5,590 shares of the exchange traded fund’s stock after selling 290 shares during the period. Alaethes Wealth LLC’s holdings in SPDR S&P Biotech ETF were worth $518,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the stock. AE Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 13.3% during the second quarter. AE Wealth Management LLC now owns 11,184 shares of the exchange traded fund’s stock worth $1,037,000 after purchasing an additional 1,314 shares during the last quarter. LHM Inc. increased its stake in SPDR S&P Biotech ETF by 22.3% in the 2nd quarter. LHM Inc. now owns 45,775 shares of the exchange traded fund’s stock valued at $4,244,000 after buying an additional 8,361 shares during the last quarter. Brighton Jones LLC bought a new position in shares of SPDR S&P Biotech ETF during the 2nd quarter worth approximately $208,000. LJI Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter worth approximately $1,890,000. Finally, Mercer Global Advisors Inc. ADV boosted its stake in shares of SPDR S&P Biotech ETF by 40.6% in the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 11,128 shares of the exchange traded fund’s stock worth $1,032,000 after buying an additional 3,214 shares during the last quarter.

SPDR S&P Biotech ETF Trading Down 0.8 %

Shares of XBI opened at $101.61 on Friday. The stock has a 50 day moving average of $99.03 and a 200 day moving average of $93.98. The company has a market capitalization of $7.74 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.